Algernon Pharmaceuticals Statistics

Total Valuation

Algernon Pharmaceuticals has a market cap or net worth of CAD 1.70 million. The enterprise value is 1.35 million.

Market Cap	1.70M
Enterprise Value	1.35M

Important Dates

The last earnings date was Monday, January 27, 2025.

Earnings Date	Jan 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Algernon Pharmaceuticals has 21.30 million shares outstanding. The number of shares has increased by 37.20% in one year.

Current Share Class	n/a
Shares Outstanding	21.30M
Shares Change (YoY)	+37.20%
Shares Change (QoQ)	+62.93%
Owned by Insiders (%)	15.71%
Owned by Institutions (%)	21.36%
Float	17.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.22
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.71
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.23

Current Ratio	0.23
Quick Ratio	0.20
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -25.89% and return on invested capital (ROIC) is -96.20%.

Return on Equity (ROE)	-25.89%
Return on Assets (ROA)	-35.42%
Return on Invested Capital (ROIC)	-96.20%
Return on Capital Employed (ROCE)	-120.55%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.67% in the last 52 weeks. The beta is -0.26, so Algernon Pharmaceuticals's price volatility has been lower than the market average.

Beta (5Y)	-0.26
52-Week Price Change	+6.67%
50-Day Moving Average	0.08
200-Day Moving Average	0.10
Relative Strength Index (RSI)	54.20
Average Volume (20 Days)	34,452

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-2.16M
Pretax Income	-362,491
Net Income	-362,491
EBITDA	-2.13M
EBIT	-2.16M
Earnings Per Share (EPS)	-0.02

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	357,923
Total Debt	n/a
Net Cash	357,923
Net Cash Per Share	0.02
Equity (Book Value)	1.79M
Book Value Per Share	0.07
Working Capital	-1.44M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.90M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Algernon Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.20%
Shareholder Yield	-37.20%
Earnings Yield	-21.27%
FCF Yield	n/a

Stock Splits

The last stock split was on March 3, 2023. It was a forward split with a ratio of 4.

Last Split Date	Mar 3, 2023
Split Type	Forward
Split Ratio	4

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a